GSTP1 and hepatocellular carcinoma: These putative DNA methylation target sites were associated with selected genes differentially repressed in HBV-Met (for example, CDKN2A, CDKN1A) or with genes being previously described as hypermethylated in HCC (for example, GSTP1 and CDH13) [15, 16].